AMZN
Amazon.com, Inc.
AMZN has the edge over DRVN overall, supported by stronger modeled upside and lower modeled downside.
DRVN
Driven Brands Holdings Inc.
DRVN's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
DRVN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
DRVN's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
DRVN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.8x | $11.53 | — |
| Current | 11x | $11.53 | — |
| Cheap | 14x | $14.15 | +23% |
| Fair | 120x | $125 | +981% |
| Expensive | 492x | $511 | +4335% |
Historical ranges are pointers, not guarantees.
DRVN has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
DRVN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
DRVN has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over DRVN on earnings, with more consistent year-over-year improvement.
DRVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.31 | +26% |
| Q2 2026 | $1.04 | +$2.74 |
| Q1 2026 | $1.12 | +$2.93 |
| Q4 2025 | $0.83 | +$2.65 |
| Q3 2025 | -$1.24 | -4233% |
| Q2 2025 | -$1.70 | +$3.01 |
| Q1 2025 | -$1.81 | +$2.86 |
| Q4 2024 | -$1.82 | +$2.71 |
| Q3 2024 | $0.03 | +$4.31 |
DRVN has returned to profit: it earned $1.04 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over DRVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
DRVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $507.4M | -7.9% |
| Q1 2026 | $484.4M | -6.1% |
| Q4 2025 | $460.1M | -18% |
| Q3 2025 | $535.7M | -9.5% |
| Q2 2025 | $551M | -9.9% |
| Q1 2025 | $516.2M | -9.8% |
| Q4 2024 | $564.1M | +1.9% |
| Q3 2024 | $591.7M | +1.8% |
DRVN's revenue has slid since its 2024 peak: $507M last quarter, down 7.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +7.5 points |
| Q1 2026 | 14% | +2.1 points |
| Q4 2025 | 17% | +74 points |
| Q3 2025 | 12% | +4.9 points |
| Q2 2025 | 6.9% | -6.2 points |
| Q1 2025 | 12% | +1.6 points |
| Q4 2024 | -57% | -65 points |
| Q3 2024 | 6.7% | +163 points |
DRVN has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
DRVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $28.9M | +221% |
| Q1 2026 | $23.1M | +22% |
| Q4 2025 | $36.2M | +$72.4M |
| Q3 2025 | $39.5M | +4.1% |
| Q2 2025 | $9M | +$28.5M |
| Q1 2025 | $18.9M | +$48.1M |
| Q4 2024 | -$36.3M | +$54.5M |
| Q3 2024 | $37.9M | +$103M |
DRVN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
DRVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +299K shares |
| 1 year | +0.5% | +786K shares |
| 3 years | -1.2% | -2M shares |
| 5 years | -0.9% | -1.6M shares |
| Available history | -0.7% | -1.1M shares |
DRVN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $49.2M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over DRVN on leverage, with a lower net debt burden relative to earnings.
DRVN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.0x | Elevated |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 5.6x | High |
| Q1 2025 | 71.8x | High |
| Q4 2024 | 63.3x | High |
| Q3 2024 | 6.4x | High |
| Q2 2023 | 5.2x | High |
| Q1 2023 | 7.5x | High |
DRVN's net debt is about 4.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
DRVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 28.0 | Neutral |
DRVN's weekly RSI is 42 (neutral) and its Stochastic is 28 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
DRVN PE vs Consumer Cyclical Sector
| Metric | DRVN | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 38% below |
| PE % | 0 | 50 | 50 pts below |
DRVN has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over DRVN on trend strength, trading above more of its moving averages.
DRVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 3.1% below |
| 20 week MA | $12.9 | 11% below |
| 50 week MA | $13.5 | 14% below |
| 100 week MA | $15.0 | 23% below |
| 200 week MA | $16.3 | 29% below |
DRVN is in a downtrend: it's below all five of its weekly moving averages, and 29% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over DRVN on returns for 2026, with the stronger performance.
DRVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.7 | $33.3 | +25% |
| 2022 | $33.3 | $26.8 | -20% |
| 2023 | $26.8 | $14.3 | -47% |
| 2024 | $14.3 | $16.2 | +14% |
| 2025 | $16.2 | $14.8 | -8.6% |
| 2026 YTD | $14.8 | $11.5 | -22% |
DRVN has finished lower in three of the last five years. It's down 22% so far in 2026.